The fifth annual NIH Cardiovascular Bioengineering (CVBE) Symposium was held in Sydney, Australia March 1-2, 2019. The unique symposium featured a combination of top international researchers and young underrepresented trainees in cardiovascular bioengineering. The event was co-organized by UAB Department of Biomedical Engineering chair Jay Zhang, M.D., Ph.D., and James Chong, Ph.D., of the University of Sydney.
“About 200 attendees from four different continents were extremely pleased with the uniqueness of the the NIH CVBE symposium,” said Zhang. “The general feeling was that the sciences are exciting, but when they combine with engineering, it changes life.”
The symposium was funded by grants from the U01 NIH NHLBI Progenitor Cell Translational Consortium (NIH PCTC) ACC and an NIH R13 grant awarded to Zhang and Joel Berry, Ph.D., by the NHLBI specifically to support the symposium. It provided a forum for trainees and junior investigators to present their work in the areas of gene editing, induced pluripotent stem cells and cardiac stem cells in the context of heart failure.
View videos of the symposium lectures here.